South & Central America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users

Description

List of Tables

The South & Central America medical exoskeleton market was valued at US$ 17.51 million in 2023 and is expected to reach US$ 134.09 million by 2031; it is estimated to register a CAGR of 29.0% from 2023 to 2031.

Increasing Prevalence of SCI Fuels South & Central America Medical Exoskeleton Market

Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people suffering from Spinal Cord Injury (SPI). Secondary complications related to SCI can also reduce life expectancies. According to the National Library of Medicine, nearly 250,000-500,000 patients suffer from SCIs every year worldwide. According to the WHO, globally, ~1.19 million people die every year in road crashes, and 20-50 million people suffer non-fatal injuries, with many incurring disabilities. Similarly, according to the Mayo Clinic estimates, sports and athletic activities such as diving in shallow water, basketball, and football cause ~10% of spinal cord injuries. Companies such as Lifeward are focusing on developing exoskeletons that help patients with SCI perform physical activities without pain. For instance, about 20% of the SCI population can be considered candidates for clinical trials of the current ReWalk Personal Exoskeleton or ReWalk Rehabilitation Exoskeleton. Moreover, soft exo-suit devices in medical exoskeletons can be used for patients suffering from SCI. Thus, the increase in the prevalence of SCI and ongoing research for the use of exoskeletons for SCI patients can be expected to fuel the market growth during the forecast period.

South & Central America Medical Exoskeleton Market Overview

Brazil is one of the most developing countries in the region, with a notable presence of healthcare facilities and technologies. R&D activities in the field of medical exoskeleton are further catalyzing the healthcare industry in Brazil at a significant rate. For instance, in November 2021, researchers at the University of Sao Paulo at Sao Carlos School of Engineering (EESC-USP) unveiled a prototype robotic exoskeleton designed to assist people who have been severely affected due to motor and sensory deficits as an aftereffect of stroke or spinal cord injury, or who have Parkinson's disease. According to the data published by the WHO, stroke deaths in Brazil reached 123,207, i.e., 10.94% of total deaths in 2020. The age-adjusted death rate is 50.40 per 100,000 people, which ranks Brazil #128 in the world. Additionally, as per Scientific Electronic Library Online, the estimated incidence of spinal cord injury in Brazil is 16 to 26 per million/year. Therefore, the rising prevalence of such conditions and an increase in research activities are expected to drive the growth of the medical exoskeleton market during the forecast period.

South & Central America Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Medical Exoskeleton Market Segmentation

The South & Central America medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the South & Central America medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the South & Central America medical exoskeleton market share in 2023.

In terms of type, the South & Central America medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the South & Central America medical exoskeleton market share in 2023.

Based on extremity, the South & Central America medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the South & Central America medical exoskeleton market share in 2023.

By application, the South & Central America medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the South & Central America medical exoskeleton market share in 2023.

In terms of mobility, the South & Central America medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the South & Central America medical exoskeleton market share in 2023.

By end users, the South & Central America medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the South & Central America medical exoskeleton market share in 2023.

Based on country, the South & Central America medical exoskeleton market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil segment held the largest share of South & Central America medical exoskeleton market in 2023.

Lifeward, Inc; Cyberdyne Inc; BIONIK; Hocoma AG; and Rex Bionics Ltd. are some of the leading companies operating in the South & Central America medical exoskeleton market.

Product Code: BMIRE00031141

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Medical Exoskeleton Market - Key Market Dynamics

4.1 South & Central America Medical Exoskeleton Market - Key Market Dynamics
4.2 Market Drivers:
- 4.2.1 Rising Number of Strategic Initiatives
- 4.2.2 Growing Incidence of Stroke and Musculoskeletal
- 4.2.3 Increasing Longevity of Aging Population
4.3 Market Restraints
- 4.3.1 High Cost of Product and Regulatory Concerns
4.4 Market Opportunities
- 4.4.1 Increasing Prevalence of SCI
4.5 Future Trends
- 4.5.1 Increasing Technological Advancements and Rising Investments
4.6 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - South & Central America Analysis

5.1 South & Central America Medical Exoskeleton Market Revenue (US$ Million), 2023-2031
5.2 South & Central America Medical Exoskeleton Market Forecast Analysis

6. South & Central America Medical Exoskeleton Market Analysis - by Component

6.1 Hardware
- 6.1.1 Overview
- 6.1.2 Hardware: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Software
- 6.2.1 Overview
- 6.2.2 Software: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. South & Central America Medical Exoskeleton Market Analysis - by Type

7.1 Powered Exoskeleton
- 7.1.1 Overview
- 7.1.2 Powered Exoskeleton: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Passive Exoskeleton
- 7.2.1 Overview
- 7.2.2 Passive Exoskeleton: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Medical Exoskeleton Market Analysis - by Extremity

8.1 Lower Body Exoskeleton
- 8.1.1 Overview
- 8.1.2 Lower Body Exoskeleton: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Upper Body Exoskeleton
- 8.2.1 Overview
- 8.2.2 Upper Body Exoskeleton: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Full Body Exoskeleton
- 8.3.1 Overview
- 8.3.2 Full Body Exoskeleton: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. South & Central America Medical Exoskeleton Market Analysis - by Application

9.1 Spinal Cord Injury
- 9.1.1 Overview
- 9.1.2 Spinal Cord Injury: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Multiple Sclerosis
- 9.2.1 Overview
- 9.2.2 Multiple Sclerosis: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Stroke
- 9.3.1 Overview
- 9.3.2 Stroke: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Cerebral Palsy
- 9.4.1 Overview
- 9.4.2 Cerebral Palsy: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Parkinson's Diseases
- 9.5.1 Overview
- 9.5.2 Parkinson's Diseases: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. South & Central America Medical Exoskeleton Market Analysis - by Mobility

10.1 Mobile Exoskeleton
- 10.1.1 Overview
- 10.1.2 Mobile Exoskeleton: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Stationary Exoskeleton
- 10.2.1 Overview
- 10.2.2 Stationary Exoskeleton: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. South & Central America Medical Exoskeleton Market Analysis - by End Users

11.1 Rehabilitation Centers
- 11.1.1 Overview
- 11.1.2 Rehabilitation Centers: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Physiotherapy Centers
- 11.2.1 Overview
- 11.2.2 Physiotherapy Centers: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Long Term Care Centers
- 11.3.1 Overview
- 11.3.2 Long Term Care Centers: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Homecare Settings
- 11.4.1 Overview
- 11.4.2 Homecare Settings: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: South & Central America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. South & Central America Medical Exoskeleton Market - Country Analysis

12.1 South & Central America Medical Exoskeleton Market
- 12.1.1 South & Central America Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.1 Brazil: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Brazil: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.1.1.1.1 Brazil: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.1.1.1.1.1 Brazil: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.1.1.2 Brazil: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.1.1.3 Brazil: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.1.1.4 Brazil: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.1.1.5 Brazil: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.1.1.6 Brazil: Medical Exoskeleton Market Breakdown, by End Users
  - 12.1.1.2 Argentina: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 Argentina: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.1.2.1.1 Argentina: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.1.2.1.1.1 Argentina: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.1.2.2 Argentina: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.1.2.3 Argentina: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.1.2.4 Argentina: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.1.2.5 Argentina: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.1.2.6 Argentina: Medical Exoskeleton Market Breakdown, by End Users
  - 12.1.1.3 Rest of South & Central America: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by Component
    - 12.1.1.3.1.1 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by Hardware
    - 12.1.1.3.1.1.1 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by Actuators
    - 12.1.1.3.2 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by Type
    - 12.1.1.3.3 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by Extremity
    - 12.1.1.3.4 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by Application
    - 12.1.1.3.5 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by Mobility
    - 12.1.1.3.6 Rest of South & Central America: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

13.1 Overview
13.2 Growth Strategies in Medical Exoskeleton Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Lifeward, Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Cyberdyne Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 BIONIK
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Hocoma AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Rex Bionics Ltd.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms